影響病人參與癌症臨床試驗之因素探討－系統性文獻回顧

Factors Influencing Patient Decisions Regarding Cancer Clinical Trial Participation: A Systematic Review

10.6224/JN.202202_69(1).11

蕭至芩(Zhi-Qin XIAO)；許家瑜(Chia-Yu HSU)；高綺吟(Chi-Yin KAO)

癌症 ； 臨床試驗 ； 動機 ； 阻礙 ； 系統性文獻回顧 ； cancer ； clinical trials ； motivation ； barrier ； systematic review

護理雜誌

69卷1期（2022 / 02 / 01）

83 - 99

繁體中文

背景：癌症為臺灣十大死因之首，癌症藥物研發需經過臨床試驗過程以確保藥物安全性與療效。暸解癌症病人參與臨床試驗的因素，有助試驗團隊瞭解病人面對癌症臨床試驗的動機與考量，進一步在知情同意過程強化病人對臨床試驗的瞭解及維護自主權。目的：以系統性文獻回顧探討影響病人參與癌症臨床試驗之因素。方法：採系統性文獻回顧法，收錄發表於Cochrane Library、Embase、PubMed、CINAHLE、Scopus五個資料庫之實證文獻，設立關鍵字與同義字為癌症、臨床試驗、參與、因素或動機、醫療決策等，發行年限由2011至2021年1月，共搜出9,353篇，經篩選、刪除重複及評讀，納入40篇符合主題文章進行分析。以安娜布里格斯學會（Joanna Briggs Institute, JBI）出版的評讀工具評析文獻品質，再依據JBI證據等級將所有文獻歸類，並萃取實證證據。結果：將影響癌症病人參與癌症臨床試驗之因素分為動機與阻礙，動機部分包含：（一）對醫療人員的信任；（二）期待治療益處；（三）沒有其他治療選擇；（四）利他；（五）得到醫療團隊詳盡的檢查與照護；（六）家人的支持；（七）重要他人或自身過去的癌症治療經驗；（八）其他與人口學因素。阻礙部分包括：（一）擔心試驗的未知副作用與治療效果；（二）無法掌握試驗的隨機分配；（三）擔心家庭經濟負擔變重；（四）無法維持生活品質；（五）因疾病歷程或變化不符合臨床試驗資格；（六）自己已有治療偏好；（七）醫療團隊對臨床試驗的負面態度；（八）家人不支持參與臨床試驗；（九）告知試驗訊息的時機不合適。結論／實務應用：本系統性文獻回顧歸納出八項參與臨床試驗動機與九項阻礙因素；顯示病人在決定是否參與癌症臨床試驗時，除了考量個人與決策情境因素，亦會考量家人與醫療團隊等因素。分析結果可幫助試驗團隊進一步在知情同意過程強化病人對臨床試驗的暸解以及病人的自主決策。

Background: Cancer is the top cause of death in Taiwan. Cancer clinical trials are crucial for developing new treatments. Understanding the motivations and barriers related to the factors of influence on patient decisions regarding participation in cancer clinical trials may help clinical researchers improve patients' understanding of clinical trials and improve their ability to make autonomous decisions regarding informed consent. Purpose: This study was designed to explore the factors affecting patient decisions regarding cancer clinical trial participation using a systematic review of the literature. Methods: A systematic review was used. Articles were retrieved from electronic databases including Cochrane Library, Embase, PubMed, CINAHLE, and Scopus. The following keywords and MeSH terms were used to search for articles on cancer, clinical trials, participation, factors or motivations, and decision making. A total of 9353 articles published from 2011 to January 2021 that matched the search criteria were extracted. After screening the topics, deleting repetitions, and doing critical appraisals, 40 articles were selected for analysis. Research quality was assessed using Joanna Briggs Institute Levels of Evidence criteria. Results: Eight motivations and nine barriers were found to significantly influence patient participation in cancer clinical trials. These motivations were: (1) trust in health professionals, (2) hope for therapeutic benefits, (3) the last treatment option, (4) altruism, (5) family support, (6) extra care, (7) patients' or others' past therapy experience, and (8) other demographic factors. The barriers to participation identified were: (1) fear of side effects or treatment efficacy, (2) concerns about trial requirements and randomization, (3) heavy financial burden, (4) inability to maintain quality of life, (5) inability to participate due to disease progression, (6) having treatment preferences, (7) health professionals' negative attitudes toward clinical trials, (8) family opposition, and (9) providing trial information at an inappropriate time. Conclusions / Implications for Practice: Eight motivational factors and nine barriers influencing patient decisions regarding cancer clinical trial participation were extracted from the selected articles. In addition to personal and situational factors, family and health professionals were found to influence patient decisions regarding cancer clinical trial participation. The authors hope that the findings of this study help clinical researchers further improve patient understanding of clinical trials and help patients make autonomous decisions with regard to informed consent.

1. Ayodele, O.,Akhtar, M.,Konenko, A.,Keegan, N.,Calacsan, F.,Duggan, L.,O’Connor, M,Calvert, P.,Townsley, C. A.,Horgan, A. M.(2016).Comparing attitudes of younger and older patients towards cancer clinical trials.Journal of Geriatric Oncology,7(3),162-168.
2. Bell, J. A. H.,Balneaves, L. G.(2015).Cancer patient decision making related to clinical trial participation: An integrative review with implications for patients’ relational autonomy.Supportive Care in Cancer,23(4),1169-1196.
3. Bidad, N.,MacDonald, L.,Winters, Z. E.,Edwards, S. J. L.,Emson, M.,Griffin, C. L.,Bliss, J.,Horne, R.(2016).How informed is declared altruism in clinical trials? A qualitative interview study of patient decision-making about the QUEST trials (quality of life after mastectomy and breast reconstruction).Trials,17(1),Article 431.
4. Biedrzycki, B. A.(2010).Decision making for cancer clinical trial participation: A systematic review.Oncology Nursing Forum,37(6),E387-E399.
5. Biedrzycki, B. A.(2011).Factors and outcomes of decision making for cancer clinical trial participation.Oncology Nursing Forum,38(5),542-552.
6. Brooks, S. E.,Carter, R. L.,Plaxe, S. C.,Basen-Engquist, K. M.,Rodriguez, M.,Kauderer, J.,Walker, J. L.,Myers, T. K. N.,Drake, J. G.,Havrilesky, L. J.,Van Le, L.,Landrum, L. M.,Brown, C. L.(2015).Patient and physician factors associated with participation in cervical and uterine cancer trials: An NRG/GOG247 study.Gynecologic Oncology,138(1),101-108.
7. Brown, R. F.,Cadet, D. L.,Houlihan, R. H.,Thomson, M. D.,Pratt, E. C.,Sullivan, A.,Siminoff, L. A.(2013).Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: What do refusers say?.Journal of Oncology Practice,9(6),287-293.
8. Carey, M.,Boyes, A. W.,Smits, R.,Bryant, J.,Waller, A.,Olver, I.(2017).Access to clinical trials among oncology patients: Results of a cross sectional survey.BMC Cancer,17(1),Article 653.
9. Dellson, P.,Nilbert, M.,Carlsson, C.(2016).Patient representatives’ views on patient information in clinical cancer trials.BMC Health Services Research,16(1),Article 36.
10. Dellson, P.,Nilsson, K.,Jernström, H.,Carlsson, C.(2018).Patients’ reasoning regarding the decision to participate in clinical cancer trials: An interview study.Trials,19(1),Article 528.
11. Dove, E. S.,Kelly, S. E.,Lucivero, F.,Machirori, M.,Dheensa, S.,Prainsack, B.(2017).Beyond individualism: Is there a place for relational autonomy in clinical practice and research?.Clinical Ethics,12(3),150-165.
12. Drevdahl, D. J.,Dorcy, K. S.(2012).Transitions, decisions, and regret: Order in chaos after a cancer diagnosis.Advances in Nursing Science,35(3),222-235.
13. Fan, R.(1997).Self-determination vs. family-determination: Two incommensurable principles of autonomy.Bioethics,11(3-4),309-322.
14. Ferrell, B.,Williams, A. C.,Borneman, T.,Chung, V.,Smith, T. J.(2019).Clinical trials: Understanding patient perspectives and beliefs about treatment.Clinical of Journal Oncology Nursing,23(6),592-598.
15. Fouad, M. N.,Lee, J. Y.,Catalano, P. J.,Vogt, T. M.,Zafar, S. Y.,West, D. W.,Simon, C.,Klabunde, C. N.,Kahn, K. L.,Weeks, J. C.,Kiefe, C. I.(2013).Enrollment of patients with lung and colorectal cancers onto clinical trials.Journal of Oncology Practice,9(2),e40-e47.
16. Fu, S.,McQuinn, L.,Naing, A.,Wheler, J. J.,Janku, F.,Falchook, G. S.,Piha-Paul, S. A.,Tu, D.,Howard, A.,Tsimberidou, A.,Zinner, R.,Hong, D. S.,Kurzrock, R.(2013).Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit.The Oncologist,18(12),1315-1320.
17. Godskesen, T.,Nygren, P.,Nordin, K.,Hansson, M.,Kihlbom, U.(2013).Phase 1 clinical trials in end-stage cancer: Patient understanding of trial premises and motives for participation.Supportive in Care Cancer,21(11),3137-3142.
18. Gregersen, T. A.,Birkelund, R.,Wolderslund, M.,Netsey-Afedo, M. L.,Steffensen, K. D.,Ammentorp, J.(2019).What matters in clinical trial decision-making: A systematic review of interviews exploring cancer patients’ experiences.Scandinavian Journal of Caring Sciences,33(2),266-278.
19. Habersack, M.,Luschin, G.(2013).Insecurities of women regarding breast cancer research: A qualitative study.PLOS ONE,8(12),Article e81770.
20. Harrop, E.,Kelly, J.,Griffiths, G.,Casbard, A.,Nelson, A.(2016).Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (bladder cancer: Open versus lapararoscopic or RObotic cystectomy).Trials,17(1),Article 35.
21. Harrop, E.,Noble, S.,Edwards, M.,Sivell, S.,Moore, B.,Nelson, A.(2016)."I didn’t really understand it, I just thought it’d help": Exploring the motivations, understandings and experiences of patients with advanced lung cancer participating in a non-placebo clinical IMP trial.Trials,17(1),Article 329.
22. Igwe, E.,Woodburn, J.,Davolos, J.,Shollenberger, C.,Miller, S. M.,Hernandez, E.,Ferriss, J. S.(2016).Patient perceptions and willingness to participate in clinical trials.Gynecolgic Oncology,142(3),520-524.
23. Jenkins, V. A.,Fallowfield, L. J.(2015).For the benefit of others: Reasons why women with breast cancer participate in RCTs.Breast Care,10(2),88-93.
24. Jiang, S.,Liu, P.,Yang, S.,Yang, J.,Wu, D.,Fang, H.,Qin, Y.,Zhou, S.,Xu, J.,Sun, Y.,Mo, H.,Gui, L.,Xing, P.,Lan, B.,Zhang, B.,Tang, L.,Sun, Y.,Shi, Y.(2019).Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: A cross-sectional study in China.BMJ Open,9(5),Article e028589.
25. Joanna Briggs Institute. (2013, October). JBI levels of evidence. https://jbi.global/sites/default/files/2019-05/JBI-Levels-ofevidence_2014_0.pdf
26. Kao, C.-Y.,Hamilton, B.,Lin, Y.-F.,Hu, W.-Y.(2019).Wardbased nurses’ knowledge and attitudes toward clinical trials: A survey study in Taiwan.Journal of Nursing Scholarship,51(4),489-496.
27. Kehl, K. L.,Arora, N. K.,Schrag, D.,Ayanian, J. Z.,Clauser, S. B.,Klabunde, C. N.,Kahn, K. L.,Fletcher, R. H.,Keating, N. L.(2014).Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.JNCI: Journal of the National Cancer Institute,106(10),Article dju216.
28. Kong, Q.,Mei, H.,Lai, Y.,Shi, S.,Li, Y.,He, L.,Qin, H.-Y.(2017).Barriers and facilitators to participation in clinical trial among lymphoma patients from Sun Yat-Sen University Cancer Center in China: An observation study.Medicine,96(37),Article e8062.
29. Lee, S. J.,Park, L. C.,Lee, J.,Kim, S.,Choi, M. K.,Hong, J. Y.,Park, S.,Maeng, C. H.,Chang, W.,Kim, Y. S.,Park, S. H.,Park, J. O.,Lim, O. Y.,Kang, W. K.,Park, Y. S.(2012).Unique perception of clinical trials by Korean cancer patients.BMC Cancer,12(1),Article 594.
30. Lim, Y.,Lim, J. M.,Jeong, W. J.,Lee, K.-H.,Keam, B.,Kim, T.-Y.,Kim, T. M.,Han, S.-W.,Oh, D. Y.,Kim, D.-W.,Kim, T.-Y.,Heo, D. S.,Bang, Y.-J.,Im, S.-A.(2017).Korean cancer patients’ awareness of clinical trials, perceptions on the benefit and willingness to participate.Cancer Research and Treatment,49(4),1033-1043.
31. Logan, J. K.,Tang, C.,Liao, Z.,Lee, J. J.,Heymach, J. V.,Swisher, S. G.,Welsh, J. W.,Zhang, J.,Lin, S. H.,Gomez, D. R.(2017).Analysis of factors affecting successful clinical trial enrollment in the context of three prospective, randomized, controlled trials.International Journal of Radiation Oncology, Biology, Physics,97(4),770-777.
32. Lorell, B. H.,Mikita, J. S.,Anderson, A.,Hallinan, Z. P.,Forrest, A.(2015).Informed consent in clinical research: Consensus recommendations for reform identified by an expert interview panel.Clinical Trials,12(6),692-695.
33. Manne, S.,Kashy, D.,Albrecht, T.,Wong, Y.-N.,Lederman Flamm, A.,Benson, A. B., III.,Miller, S.,Fleisher, L.,Buzaglo, J.,Roach, N.,Katz, M.,Ross, E.,Collins, M.,Poole, D.,Raivitch, S.,Miller, D.,Kinzy, T.,Liu, T.,Meropol, N. J.(2015).Attitudinal barriers to participation in oncology clinical trials: Factor analysis and correlates of barriers.European Journal of Cancer Care,24(1),28-38.
34. Mazouni, C.,Deneuve, J.,Arnedos, M.,Prenois, F.,Saghatchian, M.,André, F.,Bourgier, C.,Delaloge, S.(2014).Decision-making from multidisciplinary team meetings to the bedside: Factors influencing the recruitment of breast cancer patients into clinical trials.The Breast,23(2),170-174.
35. Mills, N.,Donovan, J. L.,Wade, J.,Hamdy, F. C.,Neal, D. E.,Lane, J. A.(2011).Exploring treatment preferences facilitated recruitment to randomized controlled trials.Journal of Clinical Epidemiology,64(10),1127-1136.
36. Munn, Z.,Barker, T. H.,Moola, S.,Tufanaru, C.,Stern, C.,McArthur, A.,Stephenson, M.,Aromataris, E.(2020).Methodological quality of case series studies: An introduction to the JBI critical appraisal tool.JBI Evidence Synthesis,18(10),2127-2133.
37. Nielsen, Z. E.,Berthelsen, C. B.(2019).Cancer patients’ perceptions of factors influencing their decisions on participation in clinical drug trials: A qualitative meta-synthesis.Journal of Clinical Nursing,28(13-14),2443-2461.
38. Pawlowski, J.,Malik, L.,Mahalingam, D.(2015).Advanced cancer patients’ understanding and perceptions of phase I clinical trials.Cancer Investigation,33(10),490-495.
39. Quinn, G. P.,Koskan, A.,Wells, K. J.,Gonzalez, L. E.,Meade, C. D.,Pozo, C. L. P.,Jacobsen, P. B.(2012).Cancer patients’ fears related to clinical trial participation: A qualitative study.Journal of Cancer Education,27(2),257-262.
40. Quinn, G. P.,Pratt, C. L.,Bryant-George, K.,Caraway, V. D.,Paternoster, B.,Roldan, T.,Shaffer, A.,Shimizu, C. O.,Vaughn, E. J.,Williams, C.,Bepler, G.(2011).Lung cancer patients’ decisions about clinical trials and the theory of planned behavior.Journal of Cancer Education,26(4),641-648.
41. Reeder-Hayes, K. E.,Roberts, M. C.,Henderson, G. E.,Dees, E. C.(2017).Informed consent and decision making among participants in novel-design phase I oncology trials.Journal of Oncology Practice,13(10),e863-e873.
42. Rowe, J.,Patel, S.,Mazo-Canola, M.,Parra, A.,Goros, M.,Michalek, J.,Kelly, K.,Weitman, S.,Karnad, A.(2014).An evaluation of elderly patients (≥70 years old) enrolled in phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research Center from 2009 to 2011.Journal of Geriatric Oncology,5(1),65-70.
43. Sabesan, S.,Burgher, B.,Buettner, P.,Piliouras, P.,Otty, Z.,Varma, S.,Thaker, D.(2011).Attitudes, knowledge and barriers to participation in cancer clinical trials among rural and remote patients.Asia-Pacific Journal of Clinical Oncology,7(1),27-33.
44. Shannon-Dorcy, K.,Drevdahl, D. J.(2011)."I had already made up my mind": Patients and caregivers’ perspectives on making the decision to participate in research at a US cancer referral center.Cancer Nursing,34(6),428-433.
45. Staniszewska, A.,Lubiejewska, A.,Czerw, A.,Dąbrowska-Bender, M.,Duda-Zalewska, A.,Olejniczak, D.,Juszczyk, G.,Bujalska-Zadrożny, M.(2018).Awareness and attitudes towards clinical trials among Polish oncological patients who had never participated in a clinical trial.Advances in Clinical and Experimental Medicine,27(4),525-529.
46. Sung, H.,Ferlay, J.,Siegel, R. L.,Laversanne, M.,Soerjomataram, I.,Jemal, A.,Bray, F.(2021).Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA: A Cancer Journal for Clinicians,71(3),209-249.
47. Ulrich, C. M.,Knafl, K. A.,Ratcliffe, S. J.,Richmond, T. S.,Grady, C.,Miller-Davis, C.,Wallen, G. R.(2012).Developing a model of the benefits and burdens of research participation in cancer clinical trials.AJOB Primary Research,3(2),10-23.
48. Unger, J. M.,Hershman, D. L.,Albain, K. S.,Moinpour, C. M.,Petersen, J. A.,Burg, K.,Crowley, K. B. J.(2013).Patient income level and cancer clinical trial participation.Journal of Clinical Oncology,31(5),536-542.
49. Unger, J. M.,Vaidya, R.,Hershman, D. L.,Minasian, L. M.,Fleury, M. E.(2019).Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation.JNCI: Journal of the National Cancer Institute,111(3),245-255.
50. US Food and Drug Administration. (2018, January 4). The drug development process. https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process
51. Van der Biessen, D. A. J.,Cranendonk, M. A.,Schiavon, G.,van der Holt, B.,Wiemer, E. A. C.,Eskens, F. A. L. M.,Verweij, J.,de Jonge, M. J. A.,Mathijssen, R. H. J.(2013).Evaluation of patient enrollment in oncology phase I clinical trials.The Oncologist,18(3),323-329.
52. Vanderpool, R. C.,Kornfeld, J.,Mills, L.,Byrne, M. M.(2011).Rural-urban differences in discussions of cancer treatment clinical trials.Patient Education and Counseling,85(2),e69-e74.
53. Walsh, E.,Sheridan, A.(2016).Factors affecting patient participation in clinical trials in Ireland: A narrative review.Contemporary Clinical Trials Communications,3,23-31.
54. Wang, L.-H.,Tsai, Y.-F.,Chen, J.-S.,Tsay, P.-K.(2011).Intention, needs, and expectations of cancer patients participating in clinical trials.Cancer Nursing,34(2),117-123.
55. Wong, Y.-N.,Schluchter, M. D.,Albrecht, T. L.,Benson, A. B., III.,Buzaglo, J.,Collins, M.,Flamm, A. L.,Fleisher, L.,Katz, M.,Kinzy, T. G.,Liu, T. M.,Manne, S.,Margevicius, S.,Miller, D. M.,Miller, S. M.,Poole, D.,Raivitch, S.,Roach, N.,Ross, E.,Meropol, N. J.(2016).Financial concerns about participation in clinical trials among patients with cancer.Journal of Clinical Oncology,34(5),479-487.
56. World Health Organization. (2021, September 21). Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer
57. Zaric, B.,Perin, B.,Ilic, A.,Kopitovic, I.,Matijasevic, J.,Andrijevic, L.,Secen, N.,Stanic, J.,Bijelovic, M.,Kosjerina, Z.,Antonic, M.(2011).Clinical trials in advanced stage lung cancer: A survey of patients’ opinion about their treatment.Multidisciplinary Respiratory Medicine,6(1),Article 20.
58. Zdenkowski, N.,Lynam, J.,Sproule, V.,Wall, L.,Searston, J.,Brown, S.(2019).Results of a survey of cancer patients’ willingness to travel to participate in a clinical trial.Internal Medicine Journal,49(10),1321-1325.
59. 財團法人醫藥品查驗中心（2020）．財團法人醫藥品查驗中心2019 年報。https://www.cde.org.tw/Content/ebook/CDE_eBook/2019/index.html [Center for Drug Evaluation, Taiwan. (2020). Center for Drug Evaluation 2019 annual report. https://www.cde.org.tw/Content/ebook/CDE_eBook/2019/index.html]